Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation

2013 Liu, 2019, The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention, J Hepatol, 70, 674, 10.1016/j.jhep.2018.12.001 Smittenaar, 2016, Cancer incidence and mortality projections in the UK until 2035, Br J Cancer, 115, 1147, 10.1038/bjc.2016.304 Lepage, 2015, Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: results of EUROCARE-5, Eur J Cancer, 51, 2169, 10.1016/j.ejca.2015.07.034 Estimates of the population for the UK, England and Wales, Scotland and Northern Ireland. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernireland Accessed 26 January 2021. 2020 2013 Consonni, 2012, A command to calculate age-standardized rates with efficient interval estimation, Stata J, 12, 688, 10.1177/1536867X1201200408 Henson, 2020, Data resource profile: national cancer registration dataset in England, Int J Epidemiol, 49, 10.1093/ije/dyz076 Dickman, 2015, Estimating and modeling relative survival, Stata J, 15, 186, 10.1177/1536867X1501500112 Brenner, 2004, An alternative approach to age adjustment of cancer survival rates, Eur J Cancer, 40, 2317, 10.1016/j.ejca.2004.07.007 Kearney, 2015, Validation of the completeness and accuracy of the Northern Ireland cancer registry, Cancer Epidemiol, 39, 401, 10.1016/j.canep.2015.02.005 2020 Driver, 2019, Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study, BMJ Open, 9, 10.1136/bmjopen-2018-028571 Khan, 2019, Cholangiocarcinoma: epidemiology and risk factors, Liver Int, 39, 19, 10.1111/liv.14095 DeOliveira, 2007, Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution, Ann Surg, 245, 755, 10.1097/01.sla.0000251366.62632.d3 Khan, 2012, Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?, J Hepatol, 56, 848, 10.1016/j.jhep.2011.11.015 Akinyemiju, 2017, The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015, JAMA Oncol, 3, 1683, 10.1001/jamaoncol.2017.3055 Wong, 2017, International incidence and mortality trends of liver cancer: a global profile, Sci Rep, 7, 45846, 10.1038/srep45846 Bertuccio, 2017, Global trends and predictions in hepatocellular carcinoma mortality, J Hepatol, 67, 302, 10.1016/j.jhep.2017.03.011 Ratib, 2014, Diagnosis of liver cirrhosis in England, a cohort study, 1998–2009: a comparison with cancer, Am J Gastroenterol, 109, 190, 10.1038/ajg.2013.405 Davies, 2012 Brown, 2018, The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015, Br J Cancer, 118, 1130, 10.1038/s41416-018-0029-6 2019 Pawlotsky, 2015, From non-A, non-B hepatitis to hepatitis C virus cure, J Hepatol, 62, S87, 10.1016/j.jhep.2015.02.006 Vaziri, 2019, Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy, J Viral Hepat, 26, 231, 10.1111/jvh.13022 2017 Ioannou, 2017, HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma, J Hepatol, 68, 25, 10.1016/j.jhep.2017.08.030 Kanwal, 2017, Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents, Gastroenterology, 153, 996, 10.1053/j.gastro.2017.06.012 Alavi, 2019, Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia, J Hepatol, 71, 281, 10.1016/j.jhep.2019.04.014 Shiels, 2020, Recent decline in hepatocellular carcinoma rates in the United States, Gastroenterology, 158, 1503, 10.1053/j.gastro.2019.12.030 2018 Hutchinson, 2006, Hepatitis C virus infection in Scotland: epidemiological review and public health challenges, Scott Med J, 51, 8, 10.1258/RSMSMJ.51.2.8 Clements, 2020, Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis, J Hepatol, 72, 95, 10.1016/j.jhep.2019.09.007 2018, EASL clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol, 69, 182, 10.1016/j.jhep.2018.03.019 Taylor, 2010, Multidisciplinary team working in cancer: what is the evidence?, BMJ, 340, c951, 10.1136/bmj.c951 Kesson, 2012, Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women, BMJ, 344, 10.1136/bmj.e2718 Kersten, 2013, Does in-house availability of multidisciplinary teams increase survival in upper gastrointestinal-cancer?, World J Gastrointest Oncol, 5, 60, 10.4251/wjgo.v5.i3.60 Cucchetti, 2014, Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma, J Hepatol, 61, 333, 10.1016/j.jhep.2014.03.037 Bridgewater, 2014, Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma, J Hepatol, 60, 1268, 10.1016/j.jhep.2014.01.021